ClinConnect ClinConnect Logo
Search / Trial NCT03897270

Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

Launched by ROSWELL PARK CANCER INSTITUTE · Mar 28, 2019

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new imaging technique called photoacoustic imaging to see how it can help us better understand breast tissues in women with breast cancer and in healthy women. This method uses a combination of light and sound to create images of the breast, which may provide more detailed information than traditional mammograms, especially for women with dense breast tissue. The trial is currently looking for participants, specifically women aged 65 to 74 who have suspicious breast masses or confirmed breast cancer that hasn't been surgically removed.

To be eligible for the trial, participants should be women who have undergone or will undergo a breast MRI. However, there are some exclusions, such as pregnant women, individuals who have had breast implants in the last six months, or those who can't give consent. Participants can expect to undergo some imaging procedures and help researchers learn more about how this new technique may improve breast cancer detection and diagnosis in the future. It's important to note that this study does not offer direct benefits to participants, but their involvement could contribute to advancements in breast cancer care.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women with clinically suspicious or confirmed breast cancer masses (that have not been surgically removed) and will/have already undergo/undergone breast magnetic resonance imaging (MRI).
  • Exclusion Criteria:
  • Pregnant women (there are no known risks to these procedures, but any unforeseen risks are as yet undetermined, so pregnant women will be excluded by means of a verbal confirmation at time of screening).
  • Women who have had breast implants in the previous 6 months.
  • Women who have had lumpectomy
  • Adults unable to consent.
  • Individuals who are not yet adults (infants, children, teenagers).
  • Pregnant women.
  • Prisoners.
  • There is no direct benefit of the study to any subject either non-English or English speaker. To facilitate the consent process, we will exclude non-English speaking subjects.

About Roswell Park Cancer Institute

Roswell Park Cancer Institute is a leading biomedical research and treatment center dedicated to advancing cancer care through innovative research, education, and patient-centered clinical services. Established in 1898, it is recognized for its pioneering contributions to cancer research and treatment, making significant strides in immunotherapy, precision medicine, and cancer prevention. With a commitment to translating scientific discoveries into effective therapies, Roswell Park conducts a wide range of clinical trials aimed at improving outcomes for cancer patients. Its multidisciplinary team of experts collaborates to provide comprehensive care while fostering an environment of discovery and hope for patients and their families.

Locations

Buffalo, New York, United States

Patients applied

0 patients applied

Trial Officials

Ermelinda Bonaccio

Principal Investigator

Roswell Park Cancer Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials